Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia 15Lymphoma 11Burkitt Lymphoma 9Leukemia, Biphenotypic, Acute 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Large-Cell, Anaplastic 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Down Syndrome 2Recurrence 1Philadelphia Chromosome 1Neurotoxicity Syndromes 1Neoplasms 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphoid 1Leukemia, B-Cell 1Immunoblastic Lymphadenopathy 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

haloperidol decanoate 1glutamic acid diethyl ester 1Vincristine 1Surveys and Questionnaires 1Psychiatric Rehabilitation 1Prednisolone 1Nutritional Status 1Methylprednisolone 1Lorazepam 1Glutamine 1Glutamic Acid 1Exercise 1Dietary Supplements 1Cytarabine 1Baclofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Prednisolone × Other hematologic neoplasm × Clear all
NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡